Muraglitazar (BMS-298585) is a PPAR alpha/gamma dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARalpha and PPARgamma with EC50 of 320 nM and 110 nM respectively.
Molecular Weight:
516.54
Purity:
99.17%
CAS Number:
[331741-94-7]
Formula:
C29H28N2O7
Target:
PPAR
T21587
* VAT and and shipping costs not included. Errors and price changes excepted